Physicians Formula Holdings, Inc. (MM) (NASDAQ:FACE)
Historical Stock Chart
1 Year : From Jun 2012 to Jun 2013
The law firm of Brower Piven, A Professional Corporation, is announcing
an investigation into Physician’s Formula Holdings, Inc. (“Physician’s
Formula” or the “Company”) (Nasdaq: FACE) and Swander Pace Capital’s
(“Swander Pace”) proposed merger agreement ( “Proposed Buyout”) in which
Swander Pace affiliates will acquire all outstanding shares of
Physician’s Formula’s common stock at $4.25 per share (or approximately
$65 million).
According to Bloomberg, as recently as August 6, 2012, one analyst had
set a high price target of $5.00 per share. Moreover, the EBITDA,
revenue, and total asset multiples for the Proposed Buyout are lower
than the median multiples for comparable transactions.
The Proposed Buyout, subject to various closing conditions, is expected
to close later this year. Upon completion, Physician’s Formula’s
stockholders will cease to have any equity interest in the Company and
will have no right to participate in its earnings and future growth.
If you currently own shares of Physician’s Formula and would like to
learn more about the investigation, you may email or call Brower Piven,
who will, without obligation or cost to you, attempt to answer your
questions. You may contact Brower Piven by email at hoffman@browerpiven.com,
by calling (410) 415-6616, or at Brower Piven, A Professional
Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys
at Brower Piven have combined experience litigating securities and other
class action cases of over 60 years.
| 
